title: Thrombotic thrombocytopenic purpura following terbinafine therapy.
authors.affiliation: Department of Hematology, Kaplan Medical Center, Rehovot, affiliated with Hadassah and Hebrew University Medical School, Jerusalem, Israel.
authors.forename: Kalman
authors.initials: K
authors.lastname: Filanovsky
authors.forename: Erica
authors.initials: E
authors.lastname: Sigler
authors.forename: Lev
authors.initials: L
authors.lastname: Shvidel
mesh_terms: D051722:ADAM Proteins / Q000037:antagonists & inhibitors / Q000097:blood / Q000276:immunology; D000071120:ADAMTS13 Protein; D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000097:blood; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000009:adverse effects*; D014009:Onychomycosis / Q000188:drug therapy; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D001323:Autoantibodies; D009281:Naphthalenes; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; D000077291:Terbinafine